Literature DB >> 32161976

[Treatment decisions in oncology : Walking the tightrope between honesty and hope, lifetime, and quality of life].

S Walter1, C Keinki2, J Hübner3.   

Abstract

BACKGROUND: A cancer diagnosis is always associated with a threat to life and therefore demands a great deal of the decision maker. For patients, this means making decisions under high emotional stress. On the other hand, medical facts can limit freedom of choice. For interactions with the patient in medical practice, this often means a balancing act between honesty and hope.
OBJECTIVE: This article aims to present factors that influence medical decisions in the area of conflict between ethical and moral obligations towards the patient and the daily routine of oncological care.
MATERIALS AND METHODS: The current study is a narrative review.
RESULTS: There are different decision models and decision principles, all of which are influenced by the physician-patient relationship. In oncology, informing patents with regard to lifetime and quality of life is particularly demanding. Sometimes a balancing act between honesty and hope must be made.
CONCLUSION: In every treatment situation but particularly in the palliative situation, open and honest communication is absolutely necessary. It must be ensured that the patient receives all the necessary information, understands it, and includes it in the decision-making process. An emphatic but clear naming of the medical facts allows the patient to maintain his autonomy and dignity.

Entities:  

Keywords:  Communication; Decision making, shared; Head and neck neoplasms; Palliative medicine; Problem solving

Mesh:

Year:  2020        PMID: 32161976     DOI: 10.1007/s00106-020-00842-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  24 in total

1.  The impact of awareness of terminal illness on quality of death and care decision making: a prospective nationwide survey of bereaved family members of advanced cancer patients.

Authors:  Eunmi Ahn; Dong Wook Shin; Jin Young Choi; Jina Kang; Dae Kyun Kim; Hyesuk Kim; Eunil Lee; Kwan Ok Hwang; Bumjo Oh; BeLong Cho
Journal:  Psychooncology       Date:  2013-07-10       Impact factor: 3.894

2.  Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers.

Authors:  Josephine M Clayton; Phyllis N Butow; Robert M Arnold; Martin H N Tattersall
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

3.  Decision making in head and neck cancer care.

Authors:  Louise Davies; Lorna A Rhodes; David C Grossman; Marie-Claire Rosenberg; David P Stevens
Journal:  Laryngoscope       Date:  2010-12       Impact factor: 3.325

4.  Advance Care Planning Does Not Adversely Affect Hope or Anxiety Among Patients With Advanced Cancer.

Authors:  Michael J Green; Jane R Schubart; Megan M Whitehead; Elana Farace; Erik Lehman; Benjamin H Levi
Journal:  J Pain Symptom Manage       Date:  2014-12-24       Impact factor: 3.612

Review 5.  Sustaining hope when communicating with terminally ill patients and their families: a systematic review.

Authors:  Josephine M Clayton; Karen Hancock; Sharon Parker; Phyllis N Butow; Sharon Walder; Sue Carrick; David Currow; Davina Ghersi; Paul Glare; Rebecca Hagerty; Ian N Olver; Martin H N Tattersall
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

6.  Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer.

Authors:  Da-Tong Chu; Sang-We Kim; Hon-Ki Hsu; Gürsel Cok; Jaromir Roubec; Shekhar Patil; Danail Damyanov; Teena West; Belinda Hall; Sedat Altug
Journal:  Lung Cancer       Date:  2009-03-04       Impact factor: 5.705

7.  Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

Authors:  F Efficace; G Gaidano; M Sprangers; F Cottone; M Breccia; M T Voso; G Caocci; R Stauder; A A Di Tucci; G Sanpaolo; D Selleslag; E Angelucci; U Platzbecker; F Mandelli
Journal:  Ann Oncol       Date:  2014-02       Impact factor: 32.976

8.  Promoting networks between evidence-based medicine and values-based medicine in continuing medical education.

Authors:  Myriam M Altamirano-Bustamante; Nelly F Altamirano-Bustamante; Alberto Lifshitz; Ignacio Mora-Magaña; Adalberto de Hoyos; María Teresa Avila-Osorio; Silvia Quintana-Vargas; Jorge A Aguirre; Jorge Méndez; Chiharu Murata; Rodrigo Nava-Diosdado; Oscar Martínez-González; Elisa Calleja; Raúl Vargas; Juan Manuel Mejía-Arangure; Araceli Cortez-Domínguez; Fernand Vedrenne-Gutiérrez; Perla Sueiras; Juan Garduño; Sergio Islas-Andrade; Fabio Salamanca; Jesús Kumate-Rodríguez; Alejandro Reyes-Fuentes
Journal:  BMC Med       Date:  2013-02-15       Impact factor: 8.775

9.  Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients.

Authors:  Linda Brom; H Roeline W Pasman; Guy A M Widdershoven; Maurice J D L van der Vorst; Jaap C Reijneveld; Tjeerd J Postma; Bregje D Onwuteaka-Philipsen
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

10.  Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study.

Authors:  Linda Brom; Janine C De Snoo-Trimp; Bregje D Onwuteaka-Philipsen; Guy A M Widdershoven; Anne M Stiggelbout; H Roeline W Pasman
Journal:  Health Expect       Date:  2015-12-16       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.